Cargando…
Pharmacogenetic Study of the Impact of ABCB1 Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients
Psoriasis is a chronic, T cell-mediated skin disease affecting 2–3% of the Caucasian population. Cyclosporine A is a calcineurin inhibitor that acts selectively on T cells. The cyclosporine A treatment response has been suggested to be modulated by single-nucleotide polymorphisms (SNPs) in the ABCB1...
Autores principales: | Chernov, Alexandr, Kilina, Daria, Smirnova, Tatiana, Galimova, Elvira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693450/ https://www.ncbi.nlm.nih.gov/pubmed/36432633 http://dx.doi.org/10.3390/pharmaceutics14112441 |
Ejemplares similares
-
ABCB1 and ABCC1 single-nucleotide polymorphisms in patients treated with clozapine
por: Piatkov, Irina, et al.
Publicado: (2017) -
Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial
por: Jakobsen Falk, Ingrid, et al.
Publicado: (2017) -
Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis
por: Suleman, Saima, et al.
Publicado: (2022) -
Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study
por: Caronia, Daniela, et al.
Publicado: (2011) -
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
por: Gao, Bo, et al.
Publicado: (2014)